Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6830
-0.0170 (-2.43%)
At close: Mar 27, 2026, 4:00 PM EDT
0.6595
-0.0235 (-3.44%)
After-hours: Mar 27, 2026, 7:54 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $7.82 million as of March 27, 2026. Its market cap has decreased by -40.53% in one year.
Market Cap
7.82M
Enterprise Value
-6.78M
1-Year Change
-40.53%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $7.82M, a decrease of -58.69%. That is a compound annual growth rate of -20.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 8.02M | 34.38% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 8.54M |
| PharmaCyte Biotech | 8.17M |
| Kiora Pharmaceuticals | 8.06M |
| Addex Therapeutics | 7.94M |
| TransCode Therapeutics | 7.83M |
| BiomX | 7.79M |
| Pulmatrix | 7.74M |
| Evogene | 7.39M |